Status:
COMPLETED
Adoption of Innovative Approaches to Ensure Continuity of Quality TB Services During COVID-19 Pandemic in Lusaka and Livingstone, Zambia. (Telemedicine in TB)
Lead Sponsor:
Centre for Infectious Disease Research in Zambia
Collaborating Sponsors:
Ministry of Health, Zambia
Centers for Disease Control and Prevention's COVID-19 Response International Task Force - CARES funding
Conditions:
Focus of the Study is to Evaluate DSD Models for Both TB Treatment and TPT Usiing Key Performance Indicators
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Following the negative impact of public health program services including TB services by the COVID-19 Pandemic in 2020, CIDRZ conducted a program evaluation for remote patient follow up for TB treatme...
Detailed Description
During the COVID-19 pandemic, government restrictions on movement decreased access to health care. Although DSD models have been widely adopted in HIV programs, this is a relatively new approach for T...
Eligibility Criteria
Inclusion
- TB ARM
- All ROCs presenting to chest clinic for TB treatment between February 2022 and September 2022 were considered for inclusion if:
- Diagnosed with TB (new cases or retreatment cases) 18 years and above Willing and able to provide consent Not pregnant or breastfeeding No MDR TB
- TPT ARM
- All ROCs presenting to the ART clinic between February 2022 and September 2022 were considered for inclusion if they were:
- 18 years or above virally supressed with no symptoms or diagnosis suggestive of TB on ART for more than 6 months on 6MMD Consented to participate in the project did not receive TPT in the last 3 years not pregnant or breastfeeding women not incarcerated
Exclusion
- ATT ARM
- RoCs those TB diagnosis is not confirmed
- RoCs who are less than 18 years old
- RoCs not able to provide consent for program evaluation participation
- RoCs with MDR TB
- TPT ARM
- RoCs with symptoms suggestive of TB, diagnosed or confirmed with TB diagnosis
- RoCs who received TPT in the last 3 years
- RoCs who are less than 18 years old
- RoCs not able to provide consent for program evaluation participation
- Pregnant and breastfeeding women
- Incarcerated persons
Key Trial Info
Start Date :
February 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 31 2023
Estimated Enrollment :
3318 Patients enrolled
Trial Details
Trial ID
NCT06883643
Start Date
February 4 2022
End Date
March 31 2023
Last Update
March 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lusaka and Livingstone districts
Lusaka, Lusaka Province, Zambia, 10101